List of Diagnostics Companies in Italy - 8

Adaltis S.r.l. is an international IVD company headquartered in Rome, Italy. Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases and measure human hormone responses. http://www.adaltis.net/products/ Personal LAB - fully automated 2 plate microELISA/IFA analyser NEXgen - fully automated 7 plate microELISA / IFA analyser EXTRAlab - Robotic systems for liquid handling, extraction/purification of nucleic acids Pchem Family - clinical chemistry systems for 120-500 tests/hour (Instruments and dedicated reagents). HEMO One - Point of Care Analyser (Diabetes / Vitamin deficiencies / Metabolic disorders / Inflammatory diseases) With more than 10 thousands of instruments installed worldwide, Adaltis is known for excellence in performance and innovation. Adaltis' development and production of reagents include a wide range of assays: - Diagnostic kits for detection of infection agents by real-time PCR (MOLgen Line) - MicroELISA kits (EIAgen) - Clinical Chemistry / Turbidity / Latex (CHEMgen) - Genomics & Bioinformatics MDx kits and reagents for DNA/RNA complete extraction kits providing a wide range of clinical specimens (liquids, tissue, cells etc.), compatible with most DNA extraction kits on market. Adaltis provides: Dedicated Customized Services and Antibody Production. Adaltis has a strong record in OEM / ODM development and production of systems and kits. Well known partners have experienced and enjoy the expertise and quality products of Adaltis. Adaltis is ISO 9001 and ISO 13485 certified. Our products are IVD-CE marked. All of our products are backed by dedicated application support and technical service. Customer Care Center: info@adaltis.net Sales and Marketing Office: sales@adaltis.net Order Handling and Logistics: order@adaltis.net Tel: + 39 0774 5791

Driven by our mission to advance research and improve lives, BMR Genomics serves as a trusted partner for both academic and commercial projects in the life sciences. BMR Genomics, a spin-off of the University of Padua, initially focused on providing DNA analysis to universities and research centers. BMR has grown into a leading provider of comprehensive genomics services for researchers, companies, and private individuals across the life sciences sector. In 2008, we were honored with the award for Italy's best start-up. At BMR Genomics, we offer a broad range of advanced services, including DNA sequencing (Sanger, Illumina, and Oxford Nanopore), cell authentication (Cell Profile), DNA genotyping, and bioinformatics support. Additionally, we supply life science lab products through Easy Shop and custom oligonucleotides through Custom Primer. We also cater to private individuals and professionals by providing human identification, paternity, and relative testing. Our expertise spans diverse areas such as medical diagnostics, microbiology, agriculture, veterinary science, and environmental research. With cutting-edge laboratories and a commitment to staying at the forefront of genomics and bioinformatics, we continually innovate to meet the evolving needs of the scientific community. For more information, contact us at commerciale@bmr-genomics.it.

Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.

Our strength, Your solutions CrestOptics S.p.A. is a leading company in the development and manufacturing of advanced systems for fluorescence microscopy. Thanks to our strength in R&D and engineering, we specialize in supporting the research community, biotech, and pharma industry with custom solutions tailored for ever-changing demands, paying special attention to customers' needs and scientific applications. Our story Founded in 2011 with a mission to make high-end microscopy technology accessible, we quickly achieved the necessary expertise to build top-tier systems that are indispensable for ground-breaking biological research. In November 2021 Apposite Capital, a specialist international healthcare and life science investor, acquired a majority shareholding in CrestOptics to partner with the management team and employees to accelerate market penetration globally and launch new products. Our products are supported globally by an experienced network of distributors of our branded products and integrated into prestigious and highly complex equipment, through OEM custom design or as a component. Our purpose Through our commitment to excellence, we aim to drive technological innovation in microscopy and to contribute to the advancement of scientific knowledge in various fields, including life sciences, materials research, and biomedical imaging. We have recently taken a significant step towards a more sustainable future by prioritizing the creation of long-term economic, environmental, and social benefits for all stakeholders and generations to come. The application of ESG criteria in our organization's business practices will generate significant value and impact for the scientific community.

We offer whole genome sequencing to help you understand your health, lifestyle, and the risk of inheriting diseases. Simple, clear, and personal reports.

Diasorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. Starting from 2021, the company also commercializes Life Science products. The Group was founded in 1968 and is headquartered in Saluggia (Italy). Its line of products used by diagnostic laboratories that are part of hospital facilities or operate independently can meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis and retrovirus, oncology and endocrinology. DiaSorin can offer the market an assay menu that is unique for its width and presence of specialty tests, which identify us as “the” in vitro diagnostics specialist. DiaSorin also provides Life Science products that have a wide range of applications including academic and scientific research, public health and food safety, plant pathogens detection and cell counts, viability, and cell health analyses.

Siamo un'azienda innovativa che opera nel campo dell'immunodiagnostica e della genetica molecolare. Vogliamo essere un punto di riferimento per chi come noi intende contribuire giorno dopo giorno al progresso medico-scientifico. Nei nostri laboratori studiamo soluzioni e prodotti innovativi, garantendo elevati standard qualitativi, competenza e professionalità e avvalendoci dell'esperienza maturata negli anni. Grazie a nuove e sofisticate tecnologie, siamo impegnati in sfide complesse e ambiziose con l'obiettivo di proporre soluzioni diagnostiche sempre più efficienti ed efficaci. Seguici per saperne di più!

Ulisse BioMed is a healthcare biotech company operating in diagnostics, theranostics and therapeutics with the mission to develop innovative solutions in these fields. Ulisse BioMed has three proprietary technology platforms capable of generating innovative and competitive products: Sagitta (molecular diagnostics), NanoHybrid (theranostics and diagnostics) and Aptavir (therapeutics). Ulisse BioMed owns a portfolio of intellectual properties made of 8 international patent applications that cover the three technology platforms (3 related to Sagitta, 2 related to NanoHybrid, 1 related to Aptavir and 2 transversal to the three platforms), two of them are granted in Italy and in Europe.